Показано 0 из 0
Дата |
---|
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
4.20
|
4.37
|
4.45
|
4.19
|
4.67
|
4.28
|
|
|
5 082 076.68
|
7 818.00
|
4.20
|
4.32
|
3.90
|
3.895
|
4.25
|
4.25
|
|
|
2 378 444.34
|
4 995.00
|
3.61
|
4.12
|
3.89
|
3.845
|
3.965
|
3.89
|
|
|
2 003 930.36
|
4 095.00
|
3.62
|
3.95
|
4.06
|
3.81
|
4.13
|
3.83
|
|
|
2 433 840.40
|
6 888.00
|
3.75
|
4.00
|
3.82
|
3.695
|
4.01
|
3.94
|
|
|
3 030 264.82
|
5 742.00
|
3.74
|
3.86
|
3.50
|
3.385
|
3.795
|
3.74
|
|
|
3 523 308.40
|
7 073.00
|
3.26
|
3.75
|
3.50
|
3.345
|
3.505
|
3.395
|
|
|
1 788 196.69
|
5 215.00
|
3.40
|
3.55
|
3.48
|
3.45
|
3.67
|
3.52
|
|
|
1 951 293.22
|
5 042.00
|
3.42
|
3.75
|
3.41
|
3.36
|
3.53
|
3.42
|
|
|
1 639 935.33
|
3 760.00
|
3.31
|
3.45
|
3.40
|
3.30
|
3.47
|
3.42
|
|
|
1 835 091.09
|
4 902.00
|
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis platform, XpressCF.